Migraine prevention drug Emgality added to Pharmaceutical ...

ABC News - 12 May 2021
Raphaella Crosby, founding member Migraine Australia, says the addition of Emgality to the Pharmaceutical Benefits Scheme is a step in the right direction, but ...

Headache as hundreds of thousands of migraine sufferers face medication shortage

7NEWS - 15 Feb 2024
Headache as hundreds of thousands of migraine sufferers face medication shortage ...

First-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention | Eli Lilly ...

Investors | Eli Lilly and Company - 16 Jun 2023
First-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention | Eli Lilly ... ...

Organon pays $50M to pick up rights to pair of Eli Lilly migraine meds in Europe

FiercePharma - 18 Dec 2023
Organon pays $50M to pick up rights to pair of Eli Lilly migraine meds in Europe ...

Migraine prevention drug Emgality added to Pharmaceutical Benefits Scheme in budget

ABC News - 11 May 2021
Migraine prevention drug Emgality added to Pharmaceutical Benefits Scheme in budget ...

For Episodic Migraine, Emgality Shows Efficacy but Not Superiority

hmpgloballearningnetwork.com - 24 Jul 2023
For Episodic Migraine, Emgality Shows Efficacy but Not Superiority ...

Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec

BioSpace - 19 Jun 2023
Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec ...

Organon and Lilly sign deal to supply two migraine drugs in Europe

Pharmaceutical Technology - 19 Dec 2023
Organon and Lilly sign deal to supply two migraine drugs in Europe ...

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

Business Wire - 18 Dec 2023
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines ...

Treatment boost for chronic migraine sufferers

The Medical Republic - 08 Feb 2024
Treatment boost for chronic migraine sufferers ...

Restarting CGRPs for Migraine May Lower Response Rate

Medscape - 18 Dec 2023
Restarting CGRPs for Migraine May Lower Response Rate ...

Lilly's Emgality fails to beat Pfizer option in migraine prevention

The Pharma Letter - 17 Jun 2023
Lilly's Emgality fails to beat Pfizer option in migraine prevention ...

Organon, Lilly Partner On Two Migraine Medicines

Contract Pharma - 18 Dec 2023
Organon, Lilly Partner On Two Migraine Medicines ...

Expensive migraine drug Emgality added to PBS

9News - 11 May 2021
Expensive migraine drug Emgality added to PBS ...

U.S. judge sides with Lilly vs. Teva, overturning $176M verdict

FiercePharma - 27 Sep 2023
U.S. judge sides with Lilly vs. Teva, overturning $176M verdict ...

Another chronic migraine drug PBS listed

The Medical Republic - 17 Aug 2023
Another chronic migraine drug PBS listed ...

Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults ...

Investors | Eli Lilly and Company - 27 Sep 2018
Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults ... ...

Eli Lilly's Emgality fails to top Pfizer's Nurtec in head-to-head migraine clash

FiercePharma - 20 Jun 2023
Eli Lilly's Emgality fails to top Pfizer's Nurtec in head-to-head migraine clash ...

Teva drops patent case against Lilly after two Ajovy patents deemed invalid

FiercePharma - 28 Nov 2023
Teva drops patent case against Lilly after two Ajovy patents deemed invalid ...

After Lilly accord, Organon's CEO is hungry to ink more deals

FiercePharma - 16 Feb 2024
After Lilly accord, Organon's CEO is hungry to ink more deals ...

Emgality